/ /

LATEST

B+L next-generation surgical platform features advanced retina capabilities
Laser retains limited role for management of RVO-related MEIn the current era where pharmacologic therapy is the preferred treatment for macular edema secondary to retinal vein occlusion (RVO), there is still a role for laser, according to Francesco Bandello, MD.
OCTA brings understanding to managing diabetic eye diseaseOptical coherence tomography angiography (OCTA) is a promising new approach for visualizing retinal vascular pathology in eyes with diabetic eye disease that can be expected to have even greater utility in the future pending further enhancements.
Anti-angiogenic agent, platform planned for human trialFindings from preclinical studies show that a novel intravitreal depot of an anti-angiogenic drug releases the medication over a period of at least 6 months, is well-tolerated, and prevents VEGF-induced retinal vascular leakage.
Scleral buckle technique using PPV, laser photocoagulation
Scleral buckle technique using PPV, laser photocoagulationScleral buckles and vitrectomy are the two main procedures used today to treat retinal detachments, with many surgeons performing a combination of the two.
Retinectomy-under-air solution for retina reattachment
Retinectomy-under-air solution for retina reattachmentIn complicated retinal detachment cases where the retina fails to reattach after completing the usual steps, retinectomy is a better technique than relaxing retinotomy–and the retinectomy is best done incrementally under air, said Steve Charles, MD.
New therapies for uveal melanoma target radiation toxicity, metastatic riskOngoing research for the treatment of uveal melanoma is providing hope that the future may bring new approaches for improving the safety of local therapy–along with modalities that will increase survival by reducing metastatic risk.
How to attract millennials to your practice
How to attract millennials to your practiceFaced with an increasingly competitive environment, eye surgeons need to appeal to younger patients. The way to accomplish this is relatively straightforward: Be where they are. Of course, the more challenging part of this equation is “How?”
Reduced risk of CNV after SDM laser retinal protective therapyThe dry form of age-related macular degeneration (AMD) is the most common type of the disease, but successful treatments have been elusive in patients, resulting in disease progress and visual loss.
Topical cetirizine latest therapy to treat allergic conjunctivitisOral cetirizine is one of the most used oral medications for treatment of allergic rhinitis. In May 2017, the FDA approved the first ophthalmic formulation of the second-generation histamine-1 (H1) receptor antagonist for use in treating ocular itching associated with allergic conjunctivitis.

Poll

View Results